Opportunity Radar

← Back to search

Grant

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
G
Agency
Food and Drug Administration
Sub-agency
HHS-FDA
Solicitation #
RFA-FD-25-017
Posted
Jul 11, 2025
Response due
Feb 8, 2028
Archive date
Mar 9, 2028
CFDA / Assistance listing
93.103
Award floor
$0
Award ceiling
$600,000
Contact
Kimberly.Pendleton@fda.hhs.gov
Source
Grants.gov

Description

The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.

Similar open opportunities